| |SEPTEMBER 20268546258How Biologics and Complex Therapies Are Reshaping CDMO StrategyHow Can India Pharma Bridge the Gap Between Innovation and AccessHow a Culture of Thanks Fuels Retention in HospitalsAkhil Ravi, CEO, Aurigene Pharmaceutical Services LimitedAurelien Breton, Managing Director, Servier IndiaDr. Shashank Teotia, CHRO, Paras HealthVIVID OUTLOOKAFTERWORDIndia's Hospitals Risk Falling into the U.S.-Style Fee-for-Service TrapViren Shetty, Executive Vice Chairman, Narayana Health 66Why India's Pharma Manufacturing Boom Needs More Women in Core Plant Operations50ANALYSISPHARMA SERVICES & SOLUTIONS STARTUPSREVITALIZING STARTUPS ECOSYSTEM IN INDIA'S ADVANCING PHARMA REALM564860Pharma Site Management ServicesTissue Engineering PlatformPharmaceutical DistributorManojkumar SCo-Founder & CEO,Ranjith Kumar Velusamy,Co-Founder & Chief Business Officer,Pradeep Arunachalam,Co-Founder & CXO,Biodimension TechnologyDr. Pentapalli V. N. S. H. Vardhini,Founder & Managing Director,P. Praveen Kumar,Founder & Head of Operations,Nuvaclin ResearchAkshat Jain, Director,Vize Health & Hygiene52Neutraceutical Formulation SolutionsDr. Kruthi Nanduri, Founder & Managing Director,Invictus Biocare
< Page 7 | Page 9 >